Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. SC 13D Stake Beneficial Ownership Report
  2. SC 13D Stake Beneficial Ownership Report
  3. SC 13G Stake Amended Statement of Ownership
  4. 4/A Grant or award President & CSO acquired 1,625,136 shares (grant or award)
  5. SC 13G Stake Amended Statement of Ownership
  6. 4/A Grant or award Chairman & CEO acquired 2,198,588 shares (grant or award)
  7. 8-K Event Regulation FD disclosure
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Option exercise Director acquired 4,715 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Scientific Officer acquired 16,971,560 shares (grant or award)
  16. 4 Grant or award President & CEO acquired 23,335,897 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 29 of 68 · 1,358 filings